Matthias Szabolcs
Overview
Explore the profile of Matthias Szabolcs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
2384
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang N, Xu W, Abdelhakim A, Matveyenko A, Szabolcs M, Copeland W, et al.
Eur J Med Genet
. 2024 Aug;
71:104968.
PMID: 39209150
TAF1A, a gene encoding a TATA-box binding protein involved in ribosomal RNA synthesis, is a candidate gene for pediatric cardiomyopathy as biallelic TAF1A variants were reported in two families with...
2.
Sompuram S, Vani K, Ryan L, Johnson C, Szabolcs M, Peruyero L, et al.
Am J Clin Pathol
. 2023 Feb;
159(3):274-282.
PMID: 36779320
Objectives: To evaluate a new US Food and Drug Administration (FDA)-cleared immunohistochemistry (IHC) control (IHControls [Boston Cell Standards]) comprising peptide epitopes for HER2, estrogen receptor (ER), and progesterone receptor (PR)...
3.
Canterbury C, Fernandes H, Crapanzano J, Murty V, Mansukhani M, Shu C, et al.
JTO Clin Res Rep
. 2021 Nov;
2(10):100223.
PMID: 34746883
Introduction: The 2018 updated molecular testing guidelines for patients with advanced lung cancer incorporated immunohistochemistry (IHC) analysis as an equivalent to fluorescence in situ hybridization (FISH) method recommended in 2013....
4.
Kemper P, Nauleau P, Karageorgos G, Weber R, Kwon N, Szabolcs M, et al.
Physiol Meas
. 2021 Sep;
42(10).
PMID: 34551396
Atherosclerosis is a vascular disease characterized by compositional and mechanical changes in the arterial walls that lead to a plaque buildup. Depending on its geometry and composition, a plaque can...
5.
Sahay D, Lloyd S, Rivera J, Jezioro J, McDonald J, Pitiranggon M, et al.
Environ Res
. 2021 Mar;
196:110961.
PMID: 33675803
Background: Airborne polycyclic aromatic hydrocarbons (PAH) possess carcinogenic and endocrine disrupting properties linked to mammary tumorigenesis. These effects may be initiated during a prenatal period of susceptibility to PAH activation...
6.
Debelenko L, Katsyv I, Chong A, Peruyero L, Szabolcs M, Uhlemann A
Hum Pathol
. 2020 Dec;
109:69-79.
PMID: 33321162
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was demonstrated in the placenta; however, the data on the prevalence of placental infection and associated histopathology are limited. To identify the frequency...
7.
Szabolcs M, Sauter J, Frosina D, Geronimo J, Hernandez E, Selbs E, et al.
Appl Immunohistochem Mol Morphol
. 2020 Oct;
29(1):5-12.
PMID: 33086222
We studied the suitability of commercially available monoclonal antibodies (mAbs) for the immunohistochemical (IHC) detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in standard archival specimens. Antibodies were screened...
8.
De Michele S, Remotti H, Del Portillo A, Lagana S, Szabolcs M, Saqi A
Am J Clin Pathol
. 2020 Sep;
155(1):124-132.
PMID: 32914850
Objectives: Special AT-rich binding protein 2 (SATB2) immunohistochemistry (IHC) has high sensitivity and specificity for colorectal adenocarcinoma (CRC), but data on its expression in specific subsets of pulmonary, gastric, small...
9.
Shakri A, Zhong T, Ma W, Coker C, Hegde R, Scholze H, et al.
Cancer Med
. 2020 Jul;
9(18):6766-6775.
PMID: 32730698
Nearly 80% of advanced cancer patients are afflicted with cachexia, a debilitating syndrome characterized by extensive loss of muscle mass and function. Cachectic cancer patients have a reduced tolerance to...
10.
Park D, Shakya R, Koivisto C, Pitarresi J, Szabolcs M, Kladney R, et al.
PLoS One
. 2019 Dec;
14(12):e0226714.
PMID: 31877165
Alterations of the PALB2 tumor suppressor gene have been identified in familial breast, ovarian and pancreatic cancer cases. PALB2 cooperates with BRCA1/2 proteins through physical interaction in initiation of homologous...